Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Fabhalta® (iptacopan ...
Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower ...
Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...
Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect ...
ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...
Changes associated with anemia tongue are called glossitis, otherwise known as tongue inflammation. This article explains why ...
Talazoparib plus enzalutamide boosts overall survival in metastatic castration-resistant prostate cancer, with HRR-deficient ...
Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...
Dr Ravinder K Gupta, Dr Akhilpreet Kaur Anemia is a serious global public health problem that particularly affects young ...
[47] Therefore, in all cancer patients with any degree of anemia, it is important to investigate whether there is iron deficiency. If the parameters indicate low levels of ferritin, TfSat or CHr ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
Dienes and colleagues are to be commended for discussing orthostatic hypotension, an underrecognized condition, in their recent CMAJ article.[1][1] In the extensive list of causes of orthostatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback